Ann Pharmacother

1. IBRAHIM T, Burhan M, Bin Shafiq S, Wajahat A, et al
   Efficacy and Safety of Fremanezumab in Episodic Migraine: A Systematic Review and Meta-analysis.
   Ann Pharmacother. 2026 Sep 9:10600280261480989. doi: 10.1177/10600280261480989.
   

   >> Share

   
   

   
   Cephalalgia

2. AL-SAYEGH Z, Al-Khazali S, Al-Khazali HM, Christensen RH, et al
   Depressive and anxiety symptoms during CGRP-targeted migraine prevention: A systematic review and meta-analysis.
   Cephalalgia. 2026;46:3331024261484898.
   

   >> Share

   
   
3. LI H, Xu X, Che L, Fan X, et al
   Development and external validation of a migraine analgesic usage (MAU) index for identifying high-severity migraine: A multi-center study.
   Cephalalgia. 2026;46:3331024261478621.
   

   >> Share

   
   

   
   Headache

4. FELDMAN ECH, Ernst MM, Marzouk MA, Gibler RC, et al
   Responding With Evidence and Access for Childhood Headaches (REACH) study: A comparative effectiveness trial of cognitive behavioral therapy monotherapy versus combined cognitive behavioral therapy-pharmacotherapy with amitriptyline for the prevention
   Headache. 2026 Sep 8. doi: 10.1111/head.70176.
   

   >> Share

   
   
5. VILLAR-MARTINEZ MD, Puledda F, Domingos-Belo C, Bronstein AM, et al
   Visual, vestibular, and ocular motor changes during nitroglycerin-triggered vestibular migraine.
   Headache. 2026 Sep 5. doi: 10.1111/head.70194.
   

   >> Share

   
   
6. RANSICK JM, Pejic J, Marks L, VanderPluym JH, et al
   Evaluating the study design and criteria used for status migrainosus research: A systematic review.
   Headache. 2026 Sep 5. doi: 10.1111/head.70201.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share